ImmunologyThe Lancet Infectious DiseasesPeer-reviewed
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster
Ulrika Wimmercranz Marking, Oscar Bladh, Katherina Aguilera…·Charlotte Thålin
This study shows that a monovalent XBB.1.5-adapted BNT162b2 booster vaccine enhances binding and neutralizing antibodies against XBB.1.5 and BA.2.86 in elderly individuals with prior vaccinations.
29 citationstop 1%